June 7, 2023
Virtual on Zoom
In Canada, one in three people will experience mental illness in their lifetime.
Concurrent disorders are defined as co-occurring substance use disorders with other mental health conditions. For example, up to 40% of people who are diagnosed with Major Depressive Disorder will also have a co-occurring substance use disorder. Despite the prevalence of concurrent disorders, people who live with them tend to be under-diagnosed and under-treated. When care is provided, conditions are often treated separately rather than in an integrated way.
Currently, there is a lack of understanding about the unique needs of people with concurrent disorders. We need to advance our understanding of how mental health and substance use disorders interact to develop better, more effective treatment approaches.
- Recognize the gaps and challenges in diagnosing and treating concurrent disorders.
- Explore the latest research on creating more personalized treatment approaches.
- Raise awareness of innovative treatments and opportunities for future research.
Dr. Sidney Kennedy
Executive Director of HRI
Dr. Yelena Chorny
HRI Collaborating Clinician, Chief of Addiction and Trauma Services at Homewood Health Centre (HHC)
Dr. James MacKillop
HRI Senior Scientist, Tier 1 Canada Research Chair in Translational Addiction Research, Professor of Psychiatry and Behavioural Neurosciences at McMaster University
Dr. Christian Schütz
Associate Professor (Partner), Department of Psychiatry, Faculty of Medicine, University of British Columbia